Adaptation of the WHO guideline for residual DNA in parenteral vaccines produced on continuous cell lines to a limit for oral vaccines.
Saved in:
| Title: | Adaptation of the WHO guideline for residual DNA in parenteral vaccines produced on continuous cell lines to a limit for oral vaccines. |
|---|---|
| Authors: | Lebron JA; Biologics Safety Assessment, 2 Acute Toxicology, Merck Research Laboratories, Merck & Co., Inc., West Point, Pennsylvania 19486, USA. Jose_lebron@merck.com, Troilol PJ, Pacchione S, Griffiths TG, Harper LB, Mixson LA, Jackson BE, Michna L, Barnum AB, Denisova L, Johnson CN, Maurer KL, Morgan-Hoffman S, Niu Z, Roden DF, Wang Z, Wolf JJ, Hamilton TR, Laux KM, Soper KA, Ledwith BJ |
| Source: | Developments in biologicals [Dev Biol (Basel)] 2006; Vol. 123, pp. 35-44; discussion 55-73. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Karger Country of Publication: Switzerland NLM ID: 100940058 Publication Model: Print Cited Medium: Print ISSN: 1424-6074 (Print) Linking ISSN: 14246074 NLM ISO Abbreviation: Dev Biol (Basel) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
